Biofrontera logo

Biofrontera

BFRI | NASDAQ
Chart Builder DCF Calculator
$0.57
-$0.13 (-18.58%)
At close: Nov 16, 2026, 4:00 PM ET
$0.58
+$0.02 (+2.63%)
After-hours: Nov 16, 2026, 5:23 PM ET
-18.58%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
48.5
-5.5 pts
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #315/1021 (Top 31%)

Key Statistics

Market Data

Market Cap $8.47M
1D Range
0.57 0.70
52W Range
0.57 1.61

Valuation (TTM)

PE -1.42
PB -34.84
EV/EBITDA -2.39

Valuation (NTM)

Forward PE 4.50
Forward PEG 0.02
Price Target $3.00
Loading financial charts...

Profile

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-Rho...

Sector Healthcare
Employees 89
IPO Date Oct 29, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 13, 2026
EPS
-$0.42
Miss -281.82%
REV
$9.07M
Beat +6.71%
Next Earnings
Mar 19, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$3.00
Upside
+426.32%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.